Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $2.69 Million - $3.9 Million
83,700 Added 1350.0%
89,900 $4.04 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $5.59 Million - $11.8 Million
-175,600 Reduced 96.59%
6,200 $268,000
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $4.63 Million - $7.56 Million
101,800 Added 127.25%
181,800 $11.9 Million
Q4 2022

Feb 14, 2023

SELL
$41.39 - $81.0 $2.65 Million - $5.18 Million
-64,000 Reduced 44.44%
80,000 $3.6 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $9.41 Million - $14.7 Million
130,000 Added 928.57%
144,000 $10.4 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.